Prophylactic pretreatment of mice with hematopoietic growth factors induces expansion of primitive cell compartments and results in protection against 5-fluorouracil-induced toxicity

Blood

Volumn 87, Issue 11, 1996, Pages 4581-4588

  De Haan, Gerald ^b   Dontje, Bert ^b   Engel, Christoph ^b   Loeffler, Markus ^b   Nijhof, Willem ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RECOMBINANT INTERLEUKIN 11;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CYTOTOXICITY; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030068873     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4581.bloodjournal87114581     Document Type: Article

References (35)

1. Guigon M, Mary JY, Enouf J, Frindel E: Protection of mice against lethal doses of 1-β-arabinofuranosyl-cytosine by pluripotent stem cell inhibitors. Cancer Res 42:638, 1982
2. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/MIP-1α in vivo. Blood 79:2221, 1992
3. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJH: Macrophage inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79:2605, 1992
4. Grzegorzewski K, Ruscetti FW, Usui N, Damia G, Longo DL, Carlino JA, Keller JR, Wiltrout RH: Recombinant transforming growth factor β1 and β2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J Exp Med 180:1047, 1994
5. Harrison DE, Lerner CP: Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78:1237, 1991
6. Wichmann HE, Loeffler M: Mathematical Modeling of Cell Proliferation: Stem Cell Regulation in Hemopoiesis. Boca Raton, FL, CRC, 1985
7. Goris H, Loeffler M, Bungart B, Schmitz S, Nijhof W: Hematopoiesis during thiamphenicol treatment. I. Stimulation of stem cells during eradication of intermediate cell stages. Exp Hematol 17:957, 1989
8. Loeffler M, Bungart B, Goris H, Schmitz S, Nijhof W: Hematopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation. Exp Hematol 17:962, 1989
9. de Haan G, Dontje B, Nijhof W, Loeffler M: Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: Experimental results and model analysis. Stem Cells 13:65, 1995
10. Blomberg M, Rao SS, Reilly J, Tiarks C, Ramshaw HS, Peters SO, Kittler ELW, Quesenberry PJ: Repetitive bone marrow transplant in non-myeloablated recipients. Blood 84:345a, 1994 (abstr)
11. Musashi M, Yang Y-C, Paul SR, Clark SC, Sudo T, Ogawa M: Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 88:765, 1991
12. Hangoc G, Yin T, Cooper S, Schendel P, Yang Y-C, Broxmeyer HE: In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 81:965, 1993
13. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE, The effects of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 173:1205, 1991
14. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
15. Bodine DM, Seidel NE, Zsebo KM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
16. Neben S, Donaldson D, Sieff C, Mauch P, Bodine D, Ferrara J, Yetz-Aldape J, Turner K: Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp Hematol 22:353, 1994
17. Damia G, Komschlies KL, Futami H, Back T, Gruys E, Longo DL, Keller JR, Ruscetti FW, Wiltrout RH: Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: Protection from hematological and nonhematological toxicities. Cancer Res 52:4082, 1992
18. Ploemacher RE, van der Sluys JP, van Beurden CAJ, Baert MRM, Chan PL: Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hemopoietic stem cells in the mouse. Blood 78:2527, 1991
19. Ploemacher RE, van der Loo JCM, van Beurden CAJ, Baert MRM: Wheat germ agglutinin affinity of murine hemopoietic stem cell subpopulations is an inverse function of their long-term repopulating ability in vitro and in vivo. Leukemia 7:120, 1993
20. Down JD, Ploemacher RE: Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: Different effects of host-conditioning with gamma irradiation and cytotoxic drugs. Exp Hematol 21:913, 1993
21. Neben S, Marcus K, Mauch P: Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 81:1960, 1993
22. Neben S, Anklesaria P, Greenberger J, Mauch P: Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a clonal stromal cell line. Exp Hematol 21:438, 1993
23. Wierenga PK, Konings AWT: Studies on the hyperthermic sensitivity of the murine hematopoietic stem cell compartment. I. Heat effects on clonogenic stem cells and progenitors. Exp Hematol 21:608, 1993
24. Chervenick PA, Boggs DR, Marsh JC, Cartwright GE, Wintrobe MM: Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol 215:353, 1968
25. Van Zant G: Studies of hematopoietic stem cells spared by 5-fluorouracil. J Exp Med 159:679, 1984
26. Sui X, Tsuji R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nakahata T: Gp130 and c-kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci USA 92:2859, 1995
27. Du XX, Doerschuk CM, Orazi A, Williams DA: A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after myeloablative therapy. Blood 83:33, 1994
28. Keith JR, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG: IL-11, a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestinal and mucosal biology. Stem Cells 12:79, 1994
29. Leigh BR, Khan W, Hancock SL, Knox SJ: Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation. Radiat Res 142:12, 1995
30. Molineux G, Migdalska A, Haley J, Evans GS, Dexter TM: Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood 83:3491, 1994
31. Harrison DE, Zsebo KM, Astle CM: Splenic primitive hematopoietic stem cell (PHSC) activity is enhanced by Steel Factor because of PHSC proliferation. Blood 83:3146, 1994
32. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S: Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol 22:100, 1994
33. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S: Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Exp Hematol 23:335, 1995
34. Vadhan-Raj S, Broxmeyer HE, Hittelman WN, Papadopoulos NE, Chawla SP, Fenoglio C, Cooper S, Buescher ES, Frenck Jr RW, Holian A, Perkins RC, Scheule RK, Gutterman JU, Salem P, Benjamin RS: Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: Protection at the progenitor cell level. J Clin Oncol 10:1266, 1992
35. de Haan G, Engel C, Dontje B, Loeffler M, Nijhof W: Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy. Cancer Res 55:324, 1995